| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/14/1999 | EP0907312A1 Compositions and methods for taxol biosynthesis |
| 04/14/1999 | EP0832300A4 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances |
| 04/14/1999 | EP0821694A4 Conotoxin peptides |
| 04/14/1999 | EP0777685B1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 04/14/1999 | EP0759940A4 A dna molecule encoding a mast cell function-associated antigen (mafa) |
| 04/14/1999 | EP0759934B1 Neurotensin antagonist peptides |
| 04/14/1999 | EP0725793A4 Protease-derivatized cvf |
| 04/14/1999 | EP0679659B1 Cathepsin-l-specific inhibitor polypeptide |
| 04/14/1999 | EP0669938B1 PEPTIDE DERIVATIVES OF $g(a)-MSH AND THEIR APPLICATION |
| 04/14/1999 | EP0643559B1 Diphtheria toxin receptor-binding region |
| 04/14/1999 | EP0621789B1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 04/14/1999 | EP0618814B1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 04/14/1999 | EP0550661B1 Uses of gro genes and proteins |
| 04/14/1999 | EP0548200B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 04/14/1999 | EP0455668B1 Male flower specific gene sequences |
| 04/14/1999 | CN1214084A Cold-active protease CP70 |
| 04/14/1999 | CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV |
| 04/14/1999 | CN1214080A Glycorprotein B of RFHV/KSHV subfamily of herpes viruses |
| 04/14/1999 | CN1214052A Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
| 04/13/1999 | US5894078 Transgenic mouse expressing C-100 app |
| 04/13/1999 | CA2169942C Multiple integrative vectors and yarrowia lipolytica transformants |
| 04/13/1999 | CA2158750C Monoclonal antibodies to casein kinase i polypeptides |
| 04/13/1999 | CA2116562C Morphogen-induced modulation of inflammatory response |
| 04/13/1999 | CA2079584C Methods for trans-destabilization of specific proteins in vivo |
| 04/13/1999 | CA2064046C Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof |
| 04/13/1999 | CA2000661C A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins |
| 04/13/1999 | CA1340491C Interleukin-7 |
| 04/10/1999 | CA2229440A1 Mammalian mesoderm induction early response (mier) gene family |
| 04/10/1999 | CA2225180A1 Non-mammalian mesoderm induction early response (mier) gene family |
| 04/10/1999 | CA2212991A1 Invertebrate mesoderm induction early response (mier) gene family |
| 04/10/1999 | CA2212985A1 Mammalian mesoderm induction early response (mier) gene family |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016909A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
| 04/08/1999 | WO1999016902A1 Bioassay for thyroid stimulating antibodies |
| 04/08/1999 | WO1999016893A2 Enzymatic modification |
| 04/08/1999 | WO1999016892A1 Bovine herpesvirus 2 (bhv-2) based vector and its uses |
| 04/08/1999 | WO1999016889A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | WO1999016885A1 Killer t cell receptor recognizing human immunodeficiency virus |
| 04/08/1999 | WO1999016884A1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/08/1999 | WO1999016883A2 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN |
| 04/08/1999 | WO1999016882A1 LMB GENE OF $i(STREPTOCOCCUS AGALACTIAE) |
| 04/08/1999 | WO1999016881A1 Antigen protein and nucleic acid coding for said protein |
| 04/08/1999 | WO1999016880A2 Protein involved in abscisic acid signalling |
| 04/08/1999 | WO1999016879A1 Gene promoter sequences and uses thereof |
| 04/08/1999 | WO1999016878A1 Method of regulating gene expression |
| 04/08/1999 | WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | WO1999016875A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
| 04/08/1999 | WO1999016874A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | WO1999016873A1 Anticalins |
| 04/08/1999 | WO1999016872A1 Isoforms of the human vitamin d receptor |
| 04/08/1999 | WO1999016870A1 Secreted protein zsig-11 |
| 04/08/1999 | WO1999016867A1 Transgenic model comprising tcr alpha and beta chains |
| 04/08/1999 | WO1999016866A1 A method for generating nonpathogenic, infectious birnavirus from synthetic rna transcripts |
| 04/08/1999 | WO1999016861A1 Gram negative coccoid bacterium |
| 04/08/1999 | WO1999016792A1 A polypeptides inhibiting binding between bone sialoprotein ans staphylococcal cells |
| 04/08/1999 | WO1999016791A2 Compounds and methods for regulating cell adhesion |
| 04/08/1999 | WO1999016790A1 Use of the tumour suppressor gene p33ing1 for modulation of p53 activity and in tumour diagnosis |
| 04/08/1999 | WO1999016789A1 Apoptosis-related compounds and their use |
| 04/08/1999 | WO1999016788A1 Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors |
| 04/08/1999 | WO1999016787A1 Cell death agonists |
| 04/08/1999 | WO1999016784A1 Ras-binding protein (pre1) |
| 04/08/1999 | WO1999016710A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 04/08/1999 | WO1999016467A1 Non-anaphylactic forms of allergens and their use |
| 04/08/1999 | WO1999016466A2 Vaccine compositions and methods of enhancing vaccine efficacy |
| 04/08/1999 | WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016458A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016409A2 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016408A2 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016406A2 Therapeutic method |
| 04/08/1999 | WO1999016298A1 Nepovirus resistance in grapevine |
| 04/08/1999 | WO1999009161A8 Pancreas-derived plasminogen activator inhibitor |
| 04/08/1999 | WO1999006553A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
| 04/08/1999 | WO1999006549A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES |
| 04/08/1999 | WO1999006548A3 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS |
| 04/08/1999 | WO1999006439A3 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 04/08/1999 | WO1999006438A3 Compounds with anti-ks and anti-hiv activity |
| 04/08/1999 | WO1999005521A3 Conjugate for differentiating between healthy and unhealthy tissue |
| 04/08/1999 | WO1999005269A3 Transcriptional silencer protein nrf |
| 04/08/1999 | WO1999003987A3 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 04/08/1999 | WO1999003884A3 Modified immunogenic pneumolysin, compositions and their use as vaccines |
| 04/08/1999 | WO1999003882A3 Human leukocyte calcium activated potassium channel polypeptide |
| 04/08/1999 | WO1999003508A3 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 04/08/1999 | WO1999003489A3 Methods and compositions for regulating nuclear trafficking of proteins |
| 04/08/1999 | WO1999003488A3 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 04/08/1999 | WO1999002695A3 Epitopes and active sites of paramyxoviridae proteins and uses thereof |
| 04/08/1999 | WO1999000411A3 Two new wd-40 proteins |
| 04/08/1999 | WO1998058056A9 Cartilage growth agent |
| 04/08/1999 | WO1998058053A9 Human receptor tyrosine kinase, kdr |
| 04/08/1999 | WO1998056936A9 Regulatory sequences involved in hypoxia regulated gene expression and uses thereof |
| 04/08/1999 | WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/08/1999 | WO1998056913A9 Smad6 and uses thereof |
| 04/08/1999 | WO1998056910A9 DETECTION OF LOSS OF THE WILD-TYPE huBUB1 GENE |
| 04/08/1999 | WO1998056811B1 Plant grab proteins |
| 04/08/1999 | WO1998055638A9 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof |
| 04/08/1999 | WO1998055618A9 Mitofusin genes and their uses |
| 04/08/1999 | WO1998049321A8 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 04/08/1999 | WO1998049314A8 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
| 04/08/1999 | WO1998035694A9 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |